1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
STAAR Surgical appointed David Bailey, its former President and Chief Executive Officer, as Chief Commercial Officer effective September 8, 2026. He reports to CEO Warren Foust, and the filing sets out his base salary, bonus target and equity awards, which shareholders can review in the offer letter filed as Exhibit 10.1.
Appointed Chief Commercial Officer effective September 8, 2026; reports to Warren Foust, President and CEO
Base salary at an annual rate of CHF 462,825 (approximately $575,000), with a 2026 target bonus of 60% of base salary, prorated
Initial RSU grant valued at $850,000 vesting over three years, plus a 2026 long-term incentive award valued at $1,400,000, prorated
Mr. Bailey previously served as STAAR's President and CEO from 2001 to 2008 and as President, International Operations, from 2008 to 2011
Wrap Technologies amended the employment agreements of Chief Executive Officer Scot Cohen and President and Chief Operating Officer Jared Novick and approved performance restricted stock grants to each on September 2, 2026. The awards total 6,000,000 shares and vest only if the company's market capitalization meets thresholds from $150.0 million to $506.25 million, with part of the shares also tied to a stockholder vote to increase the equity plan's authorized shares. The filing also extends the post-termination exercise period on certain prior stock options from three months to 24 months.
Scot Cohen receives 4,000,000 performance restricted stock shares; Jared Novick receives 2,000,000, approved September 2, 2026.
Shares vest in tranches when market capitalization meets $150.0 million, $225.0 million, $337.5 million and $506.25 million for 45 consecutive trading days.
1,600,000 Cohen shares and 800,000 Novick shares are void if stockholders do not approve an equity plan increase by March 15, 2027.
Both employment agreements set a $200,000 annualized base salary and a two-year initial term, with 12-month automatic renewals.
AT&T's Board increased its size from 10 to 11 members, effective September 8, 2026, and elected Fazal F. Merchant to fill the new seat. The Board determined Merchant is independent under New York Stock Exchange standards and appointed him to the Audit and Corporate Development and Finance Committees. The filing is administrative and does not report financial results or a change in leadership of the company.
Board size increased from 10 to 11 members, effective September 8, 2026
Fazal F. Merchant elected Director to fill the resulting vacancy
Merchant appointed to the Audit and Corporate Development and Finance Committees
Board determined Merchant is independent under NYSE standards
Rallybio's Chief Financial Officer, Jonathan Lieber, will move to part-time employment effective September 15, 2026, but will remain CFO and Principal Financial Officer with the same duties and authority. His employment will end when the pending business combination with Avenzo Therapeutics closes, unless it is terminated earlier.
Part-time transition effective September 15, 2026; he keeps the CFO and principal financial officer titles
Base salary of $420,000 after the transition, with benefit plan participation
No annual bonus for 2026 or any later year he is employed
Employment ends at the closing of the Avenzo merger agreement dated May 31, 2026; severance follows under his existing employment agreements
BJ's Restaurants, Inc. appointed Christopher W. Brandt and James D. White as independent directors, effective September 3, 2026. The Board's authorized seats rose from eight to ten under the company's bylaws, and the filing describes the new directors' backgrounds in restaurant marketing and public company leadership.
Effective September 3, 2026, Brandt and White joined the Board; Brandt serves on the Governance and Nominating Committee and White on the Compensation Committee.
Authorized directors increased from eight to ten under Article III, Section 2 of the Bylaws.
Brandt was President, Chief Brand Officer and Chief Marketing Officer at Chipotle Mexican Grill from 2018 to 2026.
White was Chair, President and Chief Executive Officer of Jamba Juice from 2008 to 2016.
Amazon's board elected cybersecurity executive Kevin R. Mandia as a director on September 8, 2026, and appointed him to the Audit Committee and Security Committee. He receives a restricted stock unit award for 4,086 shares that vests in three equal annual installments starting November 15, 2027, if he continues to serve. The change adds a director with cybersecurity leadership experience to oversight of audit and security matters.
Elected as director on September 8, 2026, and appointed to the Audit Committee and Security Committee
Restricted stock unit award for 4,086 shares, vesting in three equal annual installments beginning November 15, 2027
Mr. Mandia previously served as CEO of Mandiant, Inc. from June 2016 to July 2024 and is CEO of Armadin, Inc.
Filing also discloses that an employee, Kristin Mandia, is his sister-in-law, with an annual salary of $185,000
Director Frederick J. Elmy retired from the RBC Bearings board on September 3, 2026, the same day as the annual stockholder meeting. Stockholders elected the company's director nominees, ratified Ernst & Young LLP as auditor for fiscal 2027, and approved executive pay on an advisory basis, so these are routine governance outcomes.
Frederick J. Elmy retired from the Board of Directors on September 3, 2026.
Dr. Michael J. Hartnett received 27,410,015 for votes and Dolores J. Ennico received 21,681,115 for votes in the Class III director election.
Ernst & Young LLP was ratified as independent auditor for fiscal year 2027 with 29,148,374 for votes against 310,987.
Advisory say-on-pay proposal received 26,967,486 for votes against 1,172,452.
Essential Properties Realty Trust promoted Chief Operating Officer R. Max Jenkins to President and Chief Operating Officer, expanded Robert W. Salisbury's role to include Chief Strategy Officer, and named Craig Vachris Chief Investment Officer after A Joseph Peil's employment ended September 8, 2026. CEO Peter M. Mavoides continues in his role and signed a new employment agreement, which matters to shareholders because it reshapes the senior team that runs investments and strategy.
Jenkins appointed President and Chief Operating Officer; Mavoides remains Chief Executive Officer, with amended employment agreements effective September 8, 2026 running through March 31, 2031
Jenkins and Salisbury received promotion grants of long-term incentive plan units with a target grant date value of $2,000,000, vesting 50% at three and four years
Craig Vachris, with more than 20 years of commercial real estate and net lease experience, named Executive Vice President and Chief Investment Officer
Peil's employment ended September 8, 2026, and he is eligible for severance for a termination without cause
Fortune Brands Innovations appointed Peter G. Clifford as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Interim CFO Ashley George will return to her prior role as Senior Vice President, Finance. The filing also sets out Clifford's pay and inducement equity awards, which are granted outside the company's 2022 Long-Term Incentive Plan.
Clifford, 56, was CFO of Filtration Group Corporation until August 2026.
Base salary of $700,000, annual bonus target of 90% of base salary, and long-term incentive target of $1,950,000.
Inducement awards: performance-based RSUs on 130,000 shares and stock options on 65,000 shares, to be granted September 28, 2026.
Ashley George, Interim CFO, will become Senior Vice President, Finance.
Century Therapeutics added Joseph Truitt, chief executive of iECURE, Inc., as a director effective September 9, 2026, increasing the board from six to seven members. Truitt will also serve on the Compensation Committee and receive standard non-employee director pay, including a stock option award and an annual cash retainer, so the appointment adds a board member with biotechnology executive experience.
Truitt appointed effective September 9, 2026 as a Class I director with a term expiring at the 2028 Annual Meeting of Stockholders
Board size increased from six to seven directors; Truitt will serve on the Compensation Committee
Initial option grant of 148,000 shares of common stock, vesting in equal monthly installments over 36 months, plus an annual cash retainer of $40,000
Board determined Truitt is independent under Nasdaq listing rules
Joby Aviation's Board appointed Sergey Novikov, the company's Controller since June 2021, as Principal Accounting Officer on September 2, 2026, effective immediately. The filing states his pay and other arrangements continue unchanged from before the promotion, so the change is administrative and does not alter compensation terms disclosed in the filing.
Board appointed Sergey Novikov as Principal Accounting Officer on September 2, 2026, effective immediately
Novikov has been Controller since June 2021 and was acting principal accounting officer from December 13, 2024 through May 29, 2025
Compensatory arrangements continue as in effect before the promotion; he will sign the company's standard indemnification agreement
Filing states no arrangements or understandings tied to the appointment and no related-party transactions under Item 404(a)
CME Group announced senior leadership changes in its finance and legal divisions. Jack Tobin becomes Deputy Chief Financial Officer on November 2, 2026, and Chief Financial Officer in March 2027, when Lynne Fitzpatrick becomes Chief Executive Officer. The changes also bring a new General Counsel, John Marchese, and a new Chief Accounting Officer, Matthew Render, but the filing gives no financial results or figures tied to these appointments.
Jack Tobin becomes Deputy Chief Financial Officer on November 2, 2026, and Chief Financial Officer in March 2027, when Lynne Fitzpatrick becomes Chief Executive Officer.
Matthew Render succeeds Tobin as Managing Director, Chief Accounting Officer effective November 2, 2026, after joining CME Group in August 2026.
John Marchese is promoted to General Counsel, succeeding Jonathan Marcus, who has served as General Counsel since 2022 and is stepping down later this month.
Tobin previously planned to retire effective October 30, 2026, but will now continue with the company.
The New York Times Company said Executive Vice President and Chief Human Resources Officer Jacqueline Welch will step down effective January 1, 2027. The filing says she will be eligible for severance under the company's Executive Severance Plan, subject to a general release and restrictive covenants, and is entitled to payments under long-term performance awards because she meets the retirement requirements.
Jacqueline Welch steps down as Executive Vice President and Chief Human Resources Officer, effective January 1, 2027
Severance eligibility under the Executive Severance Plan is subject to a general release of claims and compliance with restrictive covenants
Welch has met the age and service requirements for Retirement under awards granted under the 2020 Incentive Compensation Plan and is entitled to payments under those awards
Genuine Parts Company said board member Court Carruthers has been appointed Chief Executive Officer-Elect, effective September 8, 2026, and will become CEO when the planned separation of its Automotive and Industrial businesses closes. The separation is targeted for the first quarter of 2027, and Will Stengel will remain Chairman and CEO until then before joining Motion as its Chairman and CEO. The changes set the leadership structure for the two standalone companies that shareholders will hold after the separation.
Court Carruthers: CEO-elect effective September 8, 2026, with a base salary of $1,000,000 that rises to $1,200,000 when he becomes CEO at closing
Separation of Automotive and Industrial businesses targeted for the first quarter of 2027
Bert Nappier named Executive Vice President, Chief Operating Officer and Chief Financial Officer, effective September 6, 2026; James Howe named Motion President and Chief Operating Officer
GPC and Motion investor days scheduled for December 8, 2026 and December 9, 2026
electroCore's board appointed Joshua Lev, its interim president and CFO, and Mike Fox, its COO, as co-Chief Executive Officers and president, effective September 8, 2026. Both will keep their current finance and operations roles and join the board as Class III directors, increasing the board from six to eight members. The filing also shows higher pay for both executives, a revised executive severance policy, and bylaw changes that tighten rules for shareholder director nominations.
Lev and Fox were named co-CEOs and president on September 8, 2026, and will remain CFO and COO, respectively.
Lev's base salary rises from $470,000 to $540,000 with a 50% target bonus; Fox's base salary rises from $505,000 to $540,000 and his target bonus rises from 40% to 50%.
Each received 55,000 restricted stock units vesting in equal annual installments over three years.
The CEO change-in-control severance formula now provides a lump sum at a 1.5x multiple, and the bylaws add stricter advance notice and group disclosure requirements for shareholder nominees.
Turn Therapeutics appointed Robert R. Redfield, M.D., former Director of the U.S. Centers for Disease Control and Prevention, as Chief Scientific Officer. The filing says he will contribute to the scientific and clinical strategy for GX-03 across several indications.
Robert R. Redfield, M.D., appointed Chief Scientific Officer, announced September 9, 2026
Redfield served as the 18th Director of the U.S. Centers for Disease Control and Prevention, from 2018 to 2021
GX-03 is being evaluated in atopic dermatitis and developed for onychomycosis, hidradenitis suppurativa, and potential additional indications
Stephen M. Hahn, M.D., former FDA Commissioner, is listed as Executive Clinical and Regulatory Lead
Ball Corporation's board elected Darlene Nicosia, CEO of Maker's Pride, and Sherry Buck, former CFO of W.L. Gore & Associates, as directors on September 8, 2026, effective September 21, 2026. The company said the two bring manufacturing, operations and finance experience to the board, and the filing discloses no financial results, guidance or deal terms.
Nicosia has been CEO of Maker's Pride since 2022 and previously held leadership roles at the Coca-Cola Company from 1993 to 2022.
Buck retired in December 2025 as CFO of W.L. Gore & Associates, a role she held from 2021, and has served on the Lennox International board since 2019.
Nicosia is expected to join the Finance and Nominating/Corporate Governance Committees; Buck is expected to join the Finance and Audit Committees.
The appointments were announced in a press release dated September 9, 2026, furnished as Exhibit 99.1.
Lyft said Michael Brous, its Head of Lyft Urban Solutions and Safety & Customer Care since November 2025, will become Chief Financial Officer effective September 28, 2026, replacing Erin Brewer, who is retiring. Brewer will advise the company through December 15, 2026, and the filing says her departure is not the result of any dispute with the company. The same day, Lyft reaffirmed its third quarter 2026 guidance for Gross Bookings, Adjusted EBITDA and Adjusted EBITDA margin, which it first gave on August 6, 2026.
Michael Brous becomes CFO effective September 28, 2026; he has been at Lyft for nearly eight years, including since 2018 through the Motivate acquisition.
Brous's employment letter sets a $650,000 annual base salary and a target annual cash bonus of 50% of base salary, subject to Board approval.
Planned equity grants include RSUs with grant date values of about $775,000 and $2,000,000, plus PSUs with a grant date value of about $775,000.
Lyft reaffirmed Q3 2026 Gross Bookings, Adjusted EBITDA and Adjusted EBITDA margin guidance and expects to report Q3 2026 earnings in November 2026.
WW International appointed Stephen J. Bye as President and Chief Executive Officer and as a director, with his start date to be set on or before November 27, 2026. Bye most recently led Ookla, and the filing discloses his employment terms, including a $850,000 base salary and a $1,500,000 signing bonus. The interim office led by the CFO and Chief Operations Officer will dissolve when he starts.
Start date is on or before November 27, 2026, as mutually agreed; the Board increases from six to seven directors on that date.
Base salary is $850,000, with a target bonus of 125% of base salary and a $1,500,000 signing bonus paid in 2027 and 2028.
Initial grant has a value of $5,100,000 and is expected in or after January 2027; severance includes two times base salary plus target bonus on a change in control.
Interim Office of the Chief Executive, formed April 3, 2026, dissolves on his start date; CFO Felicia DellaFortuna and Chief Operations Officer Jonathan Volkmann keep their current titles.
NovoCure director Timothy Scannell has retired from the board, and his seat was vacated effective September 2, 2026. The filing says the retirement after five years of service did not result from any disagreement with the company or its management.
Timothy Scannell, a director for five years, retired from the board effective September 2, 2026.
The filing states the retirement was not due to any disagreement with the company or management.
The filing contains no replacement director or new appointment.
Form 8-K was filed September 9, 2026, signed by CFO Christoph Brackmann.
Twenty One Capital, Inc. appointed David J. Goldschmidt to its Board of Directors and Audit Committee, effective September 8, 2026. He receives a $150,000 annual cash retainer, a $150,000 annual Class A Stock award, and $20,000 per year for Audit Committee service. The change adds an independent director with a financial oversight role, and the filing describes compensation terms only, with no change to operations or financial results.
David J. Goldschmidt appointed to the Board effective September 8, 2026, with term ending at the 2027 annual general meeting.
Compensation includes a $150,000 annual cash retainer and a $150,000 annual Class A Stock award under an Independent Director Agreement.
Appointed to the Audit Committee effective September 8, 2026, receiving $20,000 per year paid in monthly cash installments.
Albertsons Companies appointed Meg Whitman to its board effective September 8, 2026, and elected her Executive Chair, a role the company describes as newly created. Kim Fennebresque moves from Chair to Lead Independent Director, and the board expands from 10 to 11 members. Because Whitman is an employee, the board has determined she is not independent under NYSE rules.
Whitman's appointment is effective September 8, 2026, with a term ending at the 2027 annual meeting.
Whitman will receive an annual base salary of $100,000 and time-based restricted stock units with a grant date value of $8.9 million, vesting in one year.
Fennebresque, Chair since September 2025, is now Lead Independent Director.
Whitman will also serve as an operations and strategic advisor to CEO Susan Morris and has not been appointed to any board committee.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.